The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Is The Market Size Of The Rare Disease Genetic Testing Market Expected To Change From 2026 To 2030?
The rare disease genetic testing market size has experienced swift expansion in recent years. This market is projected to expand from $1.17 billion in 2025 to $1.33 billion in 2026, at a compound annual growth rate (CAGR) of 13.7%. The growth observed in the past can be attributed to enhancements in genomic sequencing technologies, an increase in rare disease research initiatives, greater awareness of genetic disorders, the availability of specialized diagnostic laboratories, and the proliferation of clinical genetics programs.
The rare disease genetic testing market size is projected for significant expansion in the next few years. It is expected to reach $2.18 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.1%. This anticipated growth during the forecast period is driven by factors such as the increasing demand for personalized medicine, rising investments in genomic data analytics, the expansion of population-scale genetic screening, the growing integration of genetics into routine clinical care, and advancements in bioinformatics platforms. Major trends anticipated in the same period include the increasing adoption of next-generation sequencing for rare diseases, the growing use of AI-driven variant interpretation, the expansion of comprehensive genetic testing panels, the rising integration of genetic data with clinical decision systems, and an enhanced focus on early and accurate diagnosis.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27404&type=smp
What Leading Drivers Are Supporting The Rare Disease Genetic Testing Market Expansion?
The escalating prevalence of genetic disorders is projected to fuel the expansion of the rare disease genetic testing market going forward. These disorders are health conditions resulting from anomalies in an individual’s deoxyribonucleic acid (DNA), which can be inherited from parents or manifest as new mutations. The increase in such disorders is often attributed to advancing parental age, as older parents face a greater likelihood of transmitting genetic mutations to their offspring. Rare disease genetic testing plays a crucial role in diagnosing these conditions by identifying specific mutations, thereby enabling accurate and early detection. Furthermore, it supports the development of personalized treatment plans, which leads to enhanced patient care and improved long-term health outcomes. A notable example includes data from May 2024, where the National Health Service, a UK-based government department, indicated that 17,000 people are living with sickle cell disease, an inherited genetic blood disorder, with approximately 250 new cases diagnosed each year. Consequently, the growing incidence of genetic disorders is a primary driver for the rare disease genetic testing market.
Which Segment Classifications Are Used In The Rare Disease Genetic Testing Market Segment Analysis?
The rare disease genetic testing market covered in this report is segmented –
1) By Disease Type: Immunological Disorders, Cardiovascular Disorders, Neurological Disease, Endocrine And Metabolism Disorders Diseases, Hematological Diseases, Dermatological Disease, Other Disease Types
2) By Technology: Next-Generation Sequencing, Sanger Sequencing, Polymerase Chain Reaction Based Testing, Array Based Testing, Fluorescence In Situ Hybridization, Other Technologies
3) By Specialty: Molecular Genetic Tests, Chromosomal Genetic Tests, Biochemical Genetic Tests
4) By End-User: Hospitals And Clinics, Research Laboratories And Contract Research Organizations, Diagnostic Laboratories, Other End Users
Subsegments:
1) By Immunological Disorders: Autoimmune Disorders, Allergic Conditions, Primary Immunodeficiency Disorders, Inflammatory Disorders
2) By Cardiovascular Disorders: Congenital Heart Defects, Cardiomyopathies, Aortic Aneurysms, Pulmonary Hypertension
3) By Neurological Disease: Neurodegenerative Disorders, Neuromuscular Disorders, Epileptic Syndromes, Movement Disorders
4) By Endocrine And Metabolism Disorders Diseases: Inherited Metabolic Disorders, Thyroid Disorders, Adrenal Disorders, Diabetes Related Genetic Conditions
5) By Hematological Diseases: Hemophilia, Thalassemia, Sickle Cell Disease, Clotting Disorders
6) By Dermatological Disease: Genetic Skin Disorders, Connective Tissue Disorders, Pigmentary Disorders, Keratinization Disorders
7) By Other Disease Types: Skeletal Dysplasia, Renal Genetic Disorders, Ophthalmic Genetic Conditions, Gastrointestinal Genetic Conditions
What Emerging Trends Are Seen In The Rare Disease Genetic Testing Market?
Key companies operating in the rare disease genetic testing market are concentrating on creating technologically advanced solutions, such as digital genomics platforms, to enhance the speed, accuracy, and scalability of rare disease diagnosis. Digital genomics platforms are sophisticated software systems that integrate genomic data analysis, interpretation, and reporting to streamline and accelerate genetic testing and diagnosis. For instance, in March 2025, Strand Life Sciences Private Limited, an India-based computer software company, introduced StrandOmics Portal, a digital platform aimed at improving the efficiency and accuracy of rare disease diagnosis. This portal provides clinicians with comprehensive insights into genetic variants, facilitating quicker and more precise diagnoses. It supports advanced variant interpretation, including prenatal diagnostics, and allows for independent reviews of genetic data. This launch demonstrates a strong commitment to advancing precision medicine and equipping healthcare professionals with effective tools to improve patient outcomes.
Which Firms Are Contributing To The Rare Disease Genetic Testing Market Ecosystem?
Major companies operating in the rare disease genetic testing market are Thermo Fisher Scientific Inc., Quest Diagnostics Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., Natera Inc., OPKO Health Inc., Myriad Genetics Inc., Fulgent Genetics Inc., BioReference Laboratories Inc., Invitae Corporation, Ambry Genetics Corporation, Centogene N.V., Baylor Genetics Company, PreventionGenetics, Blueprint Genetics Oy, Artemis DNA Inc., BGI Genomics Co. Ltd., GeneDx Inc., Genomics England Ltd.
Get The Full Rare Disease Genetic Testing Market Report:
https://www.thebusinessresearchcompany.com/report/rare-disease-genetic-testing-global-market-report
Which Region Leads The Rare Disease Genetic Testing Market In Terms Of Market Share?
North America was the largest region in the rare disease genetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rare disease genetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Rare Disease Genetic Testing Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/rare-disease-genetic-testing-global-market-report
Browse Through More Reports Similar to the Global Rare Disease Genetic Testing Market 2026, By The Business Research Company
Rare Diseases Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/rare-diseases-treatment-global-market-report
Clinical Diagnostics Market Report
https://www.thebusinessresearchcompany.com/report/clinical-diagnostics-global-market-report
Rare Kidney Diseases Market Report
https://www.thebusinessresearchcompany.com/report/rare-kidney-diseases-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model